HOUSTON-(Dec. 8, 2022) – With a focus on expediting the development of early-phase clinical trials and enhancing chemoimmunotherapy responses in bladder cancer, genitourinary cancer translational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results